ECEESPE2025 Poster Presentations Diabetes and Insulin (143 abstracts)
Glycemic control in people living with type 1 diabetes using the medtronic minimed™ 780 system: results from the galaxy service in greece
Aikaterini Kountouri 1 , Anna Garmpi 2 , Loukia Pliouta 1 , Sotirios Pililis 1 , Andriana Mari 1 , Zisis Kontoninas 3 , Leoni Lekkakou 1 , Parthena Giannoulaki 3 , Konstantinos Markakis 1 , Konstantinos Makrilakis 2 , Triantafyllos Didangelos 3 , Stavros Liatis 2 & Vaia Lambadiari 1
1Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Second Propaedeutic Department of internal Medicine, Athens, Greece; 2Laiko Hospital, Athens University Medical School, Diabetes Center, First Department of Propaedeutic Internal Medicine, Athens, Greece; 3University General Hospital of Thessaloniki AHEPA, Medical School, Aristotle University of Thessaloniki, Diabetes Center, First Propaedeutic Department of Internal Medicine, Thessaloniki, Greece
JOINT2660
Background: The Galaxy project supports healthcare providers in managing clinical and device data for people with diabetes.
Objective: This analysis examines glycemic control, insulin use, and device settings in adults with Type 1 Diabetes (T1D) using the MiniMed™ 780G system across three hospitals in Greece.
Methods: Device data from the two weeks preceding the most recent clinic visit were used. Sensor usage below 70% excluded subjects from the analysis. Subgroups were formed based on pump settings, and comparative analyses were applied.
Results: Data from 99 adults were analyzed (age 43. 6 ± 14. 8 years, 66. 7% female). Mean HbA1c was 7. 2±1. 5%, with 43. 5% having HbA1c <7%. Mean Glucose Management Indicator (GMI) was 6. 9±0. 5. Median Time in Range (TIR) was 76. 3 (69. 9-83. 0)% and Time Below Range was 1. 2 (0. 6-2. 0)% (Figure 1). No significant differences in glycemic metrics were observed in subgroup analysis by age, sex, BMI, diabetes duration, or presence of complications. However, the optimal pump settings group (glucose target=100mg/dL and Active Insulin Time=2 hours)had lower GMI and higher Time in Tight Range (6. 7±0. 2% vs. 7. 0±0. 3%, P = 0. 032, 54. 1% vs. 46. 3%, P = 0. 009) without significant TBR difference. TIR was higher in the optimal settings group (81 [74. 8-82. 8]% vs. 76 [71. 7-84. 5]%), though the difference was not statistically significant (P = 0. 2).
Conclusion: These findings provide a comprehensive overview of the demographics, clinical profiles, and glycemic control of MiniMed™ 780G users in Greece and they are essential for understanding the impact of the system on type 1 diabetes management.
Volume 110
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more